Oncogene - Table of Contents alert Volume 35 Issue 34

If you are unable to see the message below, click here to view.

Advertisement Four millions CpGs can't all be wrong. Diagenode's Premium RRBS kit uses a unique protocol for high efficiency of bisulfite  Lowest cost solution available!  Superior coverage - 4 million CpGs  Cost-efficient - Multiplex up to 6 samples/lane  Choose from a complete kit or our RRBS service Learn more TABLE OF CONTENTS Volume 35, Issue 34 (August 2016) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement View most cited articles - which ones have you missed? Take a look at what your colleagues have been citing across the Oncogene journal over the past two years.  Click here to visit special webpage     Review Top Epigenomic regulation of oncogenesis by chromatin remodeling R Kumar, D-Q Li, S Müller and S Knapp Oncogene 2016 35: 4423-4436; advance online publication, January 25, 2016; 10.1038/onc.2015.513 Abstract | Full Text Original Articles Top Novel strategy for a bispecific antibody: induction of dual target internalization and degradation J M Lee, S H Lee, J-W Hwang, S J Oh, B Kim, S Jung, S-h Shim, P W Lin, S B Lee, M-Y Cho, Y J Koh, S Y Kim, S Ahn, J Lee, K-m Kim, K H Cheong, J Choi and K-A Kim Oncogene 2016 35: 4437-4446; advance online publication, February 8, 2016; 10.1038/onc.2015.514 Abstract | Full Text ALKR1275Q perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN T Ueda, Y Nakata, N Yamasaki, H Oda, K Sentani, A Kanai, N Onishi, K Ikeda, Y Sera, Z-i Honda, K Tanaka, M Sata, S Ogawa, W Yasui, H Saya, J Takita and H Honda Oncogene 2016 35: 4447-4458; advance online publication, February 1, 2016; 10.1038/onc.2015.519 Abstract | Full Text Expression of a mutant prohibitin from the aP2 gene promoter leads to obesity-linked tumor development in insulin resistance-dependent manner S R Ande, K H Nguyen, G P Padilla-Meier, B L G Nyomba and S Mishra Oncogene 2016 35: 4459-4470; advance online publication, January 11, 2016; 10.1038/onc.2015.501 Abstract | Full Text GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer H Yagi, K Asanoma, T Ohgami, A Ichinoe, K Sonoda and K Kato Oncogene 2016 35: 4471-4480; advance online publication, January 25, 2016; 10.1038/onc.2015.505 Abstract | Full Text HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies P Peixoto, A Blomme, B Costanza, R Ronca, S Rezzola, A P Palacios, L Schoysman, S Boutry, N Goffart, O Peulen, P Maris, E Di Valentin, V Hennequière, E Bianchi, A Henry, P Meunier, B Rogister, R N Muller, P Delvenne, A Bellahcène, V Castronovo and A Turtoi Oncogene 2016 35: 4481-4494; advance online publication, February 8, 2016; 10.1038/onc.2015.506 Abstract | Full Text Loss of MLCK leads to disruption of cell–cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling D Y Kim and D M Helfman Oncogene 2016 35: 4495-4508; advance online publication, February 15, 2016; 10.1038/onc.2015.508 Abstract | Full Text HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4+ T cells A Kawatsuki, J-i Yasunaga, Y Mitobe, P L Green and M Matsuoka Oncogene 2016 35: 4509-4517; advance online publication, January 25, 2016; 10.1038/onc.2015.510 Abstract | Full Text Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells OPEN M A King, I G Ganley and V Flemington Oncogene 2016 35: 4518-4528; advance online publication, February 8, 2016; 10.1038/onc.2015.511 Abstract | Full Text The fibronectin/α3β1 integrin axis serves as molecular basis for keratinocyte invasion induced by βHPV S Heuser, M Hufbauer, J Steiger, J Marshall, A Sterner-Kock, C Mauch, P Zigrino and B Akgül Oncogene 2016 35: 4529-4539; advance online publication, January 25, 2016; 10.1038/onc.2015.512 Abstract | Full Text Therapeutic targeting of tetraspanin8 in epithelial ovarian cancer invasion and metastasis C S Park, T-K Kim, H G Kim, Y-J Kim, M H Jeoung, W R Lee, N K Go, K Heo and S Lee Oncogene 2016 35: 4540-4548; advance online publication, January 25, 2016; 10.1038/onc.2015.520 Abstract | Full Text Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. Explore the benefits of submitting your next research article. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.